Showing results (41-50 of 125) with videos related to

Sort By:
Pageof 13
Journal of Hematology & Oncology|October 13, 2020
The altered transcriptome of pediatric myelodysplastic syndrome revealed by RNA sequencingLorena Zubovic, Silvano Piazza, Toma Tebaldi, et al.
Haematologica|August 26, 2017
Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescentsFrédéric Millot, Joëlle Guilhot, Meinolf Suttorp, et al.
Cancers|June 26, 2026
Characteristics and Outcomes of Adolescents (15-18 Years) with Chronic Myelogenous Leukemia (CML) in Chronic Phase: The Experience of the International Registry of Childhood CMLFrédéric Millot, Morgane Froment, Lisa Durocher, et al.
Pediatric Blood & Cancer|June 10, 2017
Characteristics and outcome in patients with central nervous system involvement treated in European pediatric acute myeloid leukemia study groupsUrsula Creutzig, Michael N Dworzak, Martin Zimmermann, et al.
British Journal of Haematology|February 10, 2023
Characteristics and outcome of primary resistant disease in paediatric acute myeloid leukaemiaLene Karlsson, Daniel Cheuk, Barbara De Moerloose, et al.
Frontiers in Cell and Developmental Biology|January 25, 2021
CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands OutAnna Dal Molin, Mattias Hofmans, Enrico Gaffo, et al.
Experimental Hematology|July 1, 2015
Novel biological insights in T-cell acute lymphoblastic leukemiaKaat Durinck, Steven Goossens, Sofie Peirs, et al.
The Lancet. Haematology|September 9, 2022
Tisagenlecleucel therapy for relapsed or refractory B-cell acute lymphoblastic leukaemia in infants and children younger than 3 years of age at screening: an international, multicentre, retrospective cohort studySara Ghorashian, Elad Jacoby, Barbara De Moerloose, et al.
Haematologica|June 5, 2014
MicroRNA-128-3p is a novel oncomiR targeting PHF6 in T-cell acute lymphoblastic leukemiaEvelien Mets, Gert Van Peer, Joni Van der Meulen, et al.
Blood|April 22, 2010
Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951Barbara De Moerloose, Stefan Suciu, Yves Bertrand, et al.
Pageof 13